Prospective, Phase 3, Randomized, Multi-center, Double-blind Study of Efficacy, Tolerability & Safety of Sulopenem & Sulopenem Etzadroxil With Probenecid vs Ertapenem Followed by Ciprofloxacin for Treatment of Complicated UTI in Adults

Trial Profile

Prospective, Phase 3, Randomized, Multi-center, Double-blind Study of Efficacy, Tolerability & Safety of Sulopenem & Sulopenem Etzadroxil With Probenecid vs Ertapenem Followed by Ciprofloxacin for Treatment of Complicated UTI in Adults

Not yet recruiting
Phase of Trial: Phase III

Latest Information Update: 05 Dec 2017

At a glance

  • Drugs Sulopenem (Primary) ; Sulopenem (Primary) ; Ciprofloxacin; Probenecid
  • Indications Urinary tract infections
  • Focus Therapeutic Use
  • Sponsors Iterum Therapeutics
  • Most Recent Events

    • 25 Nov 2017 Status changed from planning to not yet recruiting.
    • 25 Jul 2017 According to an Iterum Therapeutics media release, company anticipates initiation of this clinical trial in 2018.
    • 11 Jan 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top